Targeting Pharma, Molecular Cytomics Seeks Beta Sites for 96-Well Cell-Microarray Format | GenomeWeb
Looking to attract pharmaceutical companies and large biotechs, Molecular Cytomics, a Boston, Mass.-based company that sells tools for cell microarrays, has developed a 96-well-plate format that it claims will enable users to study cells in real time at higher throughput.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.